The big bosses are about to submit a grant renewal application to the NIH and now there's this budget impasse. This means delay in the review process and release of funds if ever it gets approved. Grrrr...

We have several new (unnamed) bacterial species and novel compounds. I'll convince the boss to name them after a corporate sponsor for a fee. Nick, I you're reading this, we'll name one species as Gawkerus dentonus or Dentonus gawkerus, your choice. Want a compound named after your fiancé? We'll call the most promising drug candidate as Derrencemycin A.

Countdown to the end...